{"SPADE_UN_12400": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 10221222 B2", "Patent Link": "http://www.lens.org/lens/patent/US_10221222_B2", "Patent Type": "Granted Patent", "Publication Date": "2019-3-5", "Family Info": "WO2015112980A2,US20160333062A1,EP3096616A2,US20190202877A1,EP3096616B1,EP3096616A4,US20190202877A1,US10428126B2,EP3096616B1", "Patent Title": "Dermaseptin-type And Piscidin-type Antimicrobial Peptides", "Abstract": "Antimicrobial agents, including antimicrobial peptides (AMPs) and uses thereof. Compositions and methods of using dermaseptin-type and piscidin-type antimicrobial peptides that demonstrate activity and improved therapeutic indices against microbial pathogens. The peptide compositions demonstrate the ability to not only maintain or improve antimicrobial activity against bacterial pathogens including Gram-negative microorganisms Acinetobacter baumannii and Pseudomonas aeruginosa, but also significantly decrease hemolytic activity against human red blood cells. Specificity determinants within the AMPS change selectivity from broad spectrum antimicrobial activity to AMPS with gram-negative selectivity."}], "Sequence Information": {"SPADE ID": "SPADE_UN_12400", "Sequence": "ALWMTLKKKVLKAKAK", "Sequence Length": 16, "Peptide Name": "Sequence 13 from Patent US 10221222", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Frequent Amino Acids": "KAL", "Absent Amino Acids": "CDEFGHINOPQRSUY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 11, "Positive Residues": 6, "Negative Residues": 0, "Mass": 1857.4, "PI": 10.7, "Net Charge": 6, "Hydrophobicity": -0.13, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_04667", "Similarity": 1.0, "Sequence": "ATKKNGRKLCLDLQAALWKKK"}, {"SPADE_ID": "SPADE_UN_04691", "Similarity": 1.0, "Sequence": "TKKNGRKLCLDLQAALWKKK"}, {"SPADE_ID": "SPADE_UN_11929", "Similarity": 1.0, "Sequence": "GAKYAKIIYNYLKKIANALW"}]}}}